Status:

RECRUITING

Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study

Lead Sponsor:

Case Comprehensive Cancer Center

Conditions:

Tumors Metastatic to Brain

Eligibility:

All Genders

18+ years

Phase:

PHASE1

PHASE2

Brief Summary

This Phase I/II trial studies the ability to stop brain metastases from coming back after treatment with radiosurgery followed by surgical resection. It will also evaluate the side effects of these co...

Detailed Description

PRIMARY OBJECTIVES: I. To determine the safety (risk of acute and long-term toxicities) of neoadjuvant radiosurgery at escalating doses followed by surgical resection of brain metastases. (Phase I) ...

Eligibility Criteria

Inclusion

  • Have a prior histologic diagnosis of cancer other than small cell lung cancer, lymphoma, and germ cell histologies
  • Magnetic resonance imaging (MRI) evidence of 1-4 brain metastases, with at least one lesion \> 20 mm and ≤ 50 mm in maximal diameter and determined to be appropriate for SRS and gross total resection; all other brain metastases are appropriate for SRS
  • Patient can have prior SRS to lesions other than the one planned for neoadjuvant SRS and resection
  • Patient must have a Karnofsky performance score of ≥ 70

Exclusion

  • Patient deemed medically unfit to undergo surgical resection of brain metastasis
  • Prior whole brain radiotherapy
  • Patient with contraindication for imaging with MRI
  • Inability to participate in study activities due to physical or mental limitations
  • Inability or unwillingness to return for all the required follow-up visits
  • At the time of planning, unable to deliver 10 Gray (Gy) or less to optic nerve/chiasm
  • Tumor located in the brainstem
  • Imaging or cytologic evidence of leptomeningeal disease

Key Trial Info

Start Date :

July 3 2013

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2025

Estimated Enrollment :

36 Patients enrolled

Trial Details

Trial ID

NCT01891318

Start Date

July 3 2013

End Date

December 1 2025

Last Update

July 2 2025

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center

Cleveland, Ohio, United States, 44106

2

Cleveland Clinic, Case Comprehensive Cancer Center

Cleveland, Ohio, United States, 44195